HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Beibei Yin Selected Research

Beibei Yin Research Topics

Disease

7Neoplasms (Cancer)
01/2022 - 11/2012
4Lung Neoplasms (Lung Cancer)
02/2018 - 04/2012
2Carcinoma (Carcinomatosis)
02/2018 - 08/2016
2Hypoxia (Hypoxemia)
02/2018 - 08/2016
2Genetic Predisposition to Disease (Genetic Predisposition)
02/2013 - 04/2012
1Triple Negative Breast Neoplasms
01/2021
1Breast Neoplasms (Breast Cancer)
01/2021
1Fatigue
01/2020
1Cough
01/2020
1Pneumonia (Pneumonitis)
01/2020
1Disease Progression
01/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020
1Organizing Pneumonia
01/2020
1Ovarian Neoplasms (Ovarian Cancer)
10/2019
1Stomach Neoplasms (Stomach Cancer)
01/2015
1Inflammation (Inflammations)
02/2013
1Adenocarcinoma
11/2012
1Brain Neoplasms (Brain Tumor)
11/2012
1Neoplasm Metastasis (Metastasis)
11/2012

Drug/Important Bio-Agent (IBA)

3Immune Checkpoint InhibitorsIBA
01/2022 - 01/2020
3pembrolizumabIBA
01/2022 - 01/2020
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2018 - 04/2012
3Interleukin-6 (Interleukin 6)IBA
02/2018 - 02/2013
2atezolizumabIBA
01/2022 - 01/2021
2Docetaxel (Taxotere)FDA Link
10/2019 - 01/2015
2InterferonsIBA
02/2018 - 08/2016
2Interleukin-17 (Interleukin 17)IBA
02/2018 - 08/2016
2Interleukin-10 (Interleukin 10)IBA
02/2018 - 08/2016
2InterleukinsIBA
02/2018 - 08/2016
2EndostatinsIBA
02/2018 - 08/2016
2Biomarkers (Surrogate Marker)IBA
02/2013 - 04/2012
1avelumabIBA
01/2022
1IpilimumabIBA
01/2022
1cemiplimabIBA
01/2022
1Programmed Cell Death 1 ReceptorIBA
01/2022
1durvalumabIBA
01/2022
1NivolumabIBA
01/2022
1PlatinumIBA
01/2020
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2018
1Phosphates (Orthophosphate)IBA
08/2016
1Transforming Growth Factors (Transforming Growth Factor)IBA
08/2016
1EnzymesIBA
08/2016
1Neoplasm Antigens (Tumor Antigens)IBA
08/2016
1Therapeutic UsesIBA
01/2015
1StathminIBA
01/2015
1OligodeoxyribonucleotidesIBA
01/2015
1CytokinesIBA
02/2013
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2013
1Cisplatin (Platino)FDA LinkGeneric
11/2012
1Pemetrexed (MTA)FDA Link
11/2012

Therapy/Procedure

4Therapeutics
01/2021 - 11/2012
3Drug Therapy (Chemotherapy)
01/2021 - 11/2012
2Immunotherapy
01/2022 - 01/2021
1Subcutaneous Injections
08/2016